AI’s Biopharma Revolution: From Lab to Patient explores how artificial intelligence is transforming the biopharmaceutical lifecycle, from early discovery through clinical development and patient delivery. The episode breaks down how AI and machine learning are being applied to drug discovery, trial design, data analysis, and decision-making, accelerating timelines while reshaping how organizations approach innovation and risk.
The conversation also examines the regulatory and quality implications of AI adoption, including data integrity, model validation, and FDA expectations as these technologies move closer to real-world use. Rather than treating AI as a futuristic concept, this episode focuses on practical applications, real challenges, and what biopharma companies need to consider to responsibly integrate AI into regulated environments while maintaining patient safety and compliance.
